Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy;Pathogenetische differenzierung des skelettsuperscans mittels knochenmarkszintigraphie

NuklearMedizin

Volumn 37, Issue 4, 1998, Pages 156-158

  Weckesser, M ^a   Muller Mattheis V G O ^a   Vosberg, H ^a   Muller Gartner H W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bone marrow scintigraphy; Bone scintigraphy; Prostatic carcinoma; Superscan

Indexed keywords

ANTIANDROGEN; FOSFESTROL; TECHNETIUM COMPLEX;

ADULT; ARTICLE; BONE MARROW SCINTISCANNING; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; HORMONAL THERAPY; HUMAN; MALE; PROSTATE CARCINOMA;

EID: 0031866773     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632318     Document Type: Article

References (12)

1. Berna L, Torres G, Carrio I, Estorch M, Germa JR, Alonso C. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance. Clin Nucl Med 1994; 19: 121-8.
2. Constable AR, Cranage RW. Recognition of the superscan in prostatic bone scintigraphy. Br J Radiol 1981; 54: 122-5.
3. Fogelman I, Greig WR, Bessent RG, Boyle IT. Skeletal uptake of Tc-99-m-HEDP in primary hyperparathyroidism. J Nucl Med 1977; 18: 1040-1.
4. Fogelman I, McKillop JH, Bessent RG, Boyle IT, Turner JG, Greig WR. The role of bone scanning in osteomalacia. J Nucl Med 1978; 19: 245-8.
5. Fogelman I, Maisey MN, Clarke SEM (eds.). An Atlas of Clinical Nuclear Medicine. Second Edition, 1994: Deutscher Ärzteverlag Köln.
6. Johansson JE, Andersson SO, Krusemo UB, Adami HO, Bergström R, Kraaz W. Natural history of localised prostatic cancer. Lancet 1989; 1 (8642): 799-803.
7. de Graaf P, Schicht IM, Pauwels EKJ, te Velde J, De Graeff J. Bone scintigraphy in renal osteodystrophy. J Nucl Med 1978; 19: 1289-96.
8. Knudson G, Grinis G, Lopez-Majano V, Sansi P, Targonski P, Rubenstein M, Sharifi R, Guinan P. Bone scan as a stratification variable in advanced prostate cancer. Cancer 1991; 68: 316-20.
9. Lunia SL, Heravi M, Goel V, Pitfalls of absent or faint kidney sign on bone scan. J Nucl Med 1980; 21: 894-5.
10. Munz DL. Knochenmarkszintigraphie. Prinzipien, klinische Ergebnisse und Indikationen. Radiologe 1992; 32: 485-94.
11. O'Donoghue EPN, Constable AR, Sherwood T, Stevenson JJ, Chisholm GD. Bone scanning and plasma phosphatases in carcinoma of the prostate. Br J Urol 1978; 50: 172-7.
12. 99mTc-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases. Am J Roentgenol 1975; 125: 972-7.